Burns JC - Search Results

1

Temporal clustering of Kawasaki disease cases around the world.

Burney JA, DeHaan LL, Shimizu C, Bainto EV, Newburger JW, DeBiasi RL, Dominguez SR, Portman MA, Melish M, Bratincsak A, Fabi M, Corinaldesi E, Yu JJ, Gee P, Kitano N, Tremoulet AH, Cayan DR, Burns JC; Kawasaki Disease Climate Study Group. Burney JA, et al. Among authors: burns jc. Sci Rep. 2021 Nov 19;11(1):22584. doi: 10.1038/s41598-021-01961-5. Sci Rep. 2021. PMID: 34799633 Free PMC article.

2

Erythrocyte sedimentation rate and C-reactive protein discrepancy and high prevalence of coronary artery abnormalities in Kawasaki disease.

Anderson MS, Burns J, Treadwell TA, Pietra BA, Glodé MP. Anderson MS, et al. Pediatr Infect Dis J. 2001 Jul;20(7):698-702. doi: 10.1097/00006454-200107000-00011. Pediatr Infect Dis J. 2001. PMID: 11465843

3

Recurrent Kawasaki disease-like syndrome in a patient with acquired immunodeficiency syndrome.

Blanchard JN, Powell HC, Freeman WR, Letendre S, Blanchard D, Shimizu C, Burns JC. Blanchard JN, et al. Among authors: burns jc. Clin Infect Dis. 2003 Jan 1;36(1):105-11. doi: 10.1086/345465. Epub 2002 Dec 13. Clin Infect Dis. 2003. PMID: 12491210

4

Organization and expression analysis of the zebrafish hepcidin gene, an antimicrobial peptide gene conserved among vertebrates.

Shike H, Shimizu C, Lauth X, Burns JC. Shike H, et al. Among authors: burns jc. Dev Comp Immunol. 2004 Jun;28(7-8):747-54. doi: 10.1016/j.dci.2003.11.009. Dev Comp Immunol. 2004. PMID: 15043943

5

Kawasaki syndrome.

Burns JC, Glodé MP. Burns JC, et al. Lancet. 2004 Aug 7-13;364(9433):533-44. doi: 10.1016/S0140-6736(04)16814-1. Lancet. 2004. PMID: 15302199 Review.

6

Quantitation of adenovirus genome during acute infection in normal children.

Shike H, Shimizu C, Kanegaye J, Foley JL, Burns JC. Shike H, et al. Among authors: burns jc. Pediatr Infect Dis J. 2005 Jan;24(1):29-33. doi: 10.1097/01.inf.0000148882.97399.79. Pediatr Infect Dis J. 2005. PMID: 15665707 Free PMC article.

7

Seasonality and temporal clustering of Kawasaki syndrome.

Burns JC, Cayan DR, Tong G, Bainto EV, Turner CL, Shike H, Kawasaki T, Nakamura Y, Yashiro M, Yanagawa H. Burns JC, et al. Epidemiology. 2005 Mar;16(2):220-5. doi: 10.1097/01.ede.0000152901.06689.d4. Epidemiology. 2005. PMID: 15703537 Free PMC article.

8

Infliximab treatment for refractory Kawasaki syndrome.

Burns JC, Mason WH, Hauger SB, Janai H, Bastian JF, Wohrley JD, Balfour I, Shen CA, Michel ED, Shulman ST, Melish ME. Burns JC, et al. J Pediatr. 2005 May;146(5):662-7. doi: 10.1016/j.jpeds.2004.12.022. J Pediatr. 2005. PMID: 15870671

9

Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease.

Burns JC, Shimizu C, Gonzalez E, Kulkarni H, Patel S, Shike H, Sundel RS, Newburger JW, Ahuja SK. Burns JC, et al. J Infect Dis. 2005 Jul 15;192(2):344-9. doi: 10.1086/430953. Epub 2005 Jun 8. J Infect Dis. 2005. PMID: 15962231 Free PMC article.

10

Familial occurrence of Kawasaki syndrome in North America.

Dergun M, Kao A, Hauger SB, Newburger JW, Burns JC. Dergun M, et al. Among authors: burns jc. Arch Pediatr Adolesc Med. 2005 Sep;159(9):876-81. doi: 10.1001/archpedi.159.9.876. Arch Pediatr Adolesc Med. 2005. PMID: 16143748 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

463 results

Search Page